logo
Sign InSign Up

AGILENT TECHNOLOGIES INC (A)

Sector: Healthcare

Financial Fundamentals

findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for A, sign up here.

Income Statement

Revenue

$6.7bn

Gross Profit

$3.4bn

Earning before Tax

$1.3bn

Net Income

$1.2bn

Net Income Common Shareholders

$1.2bn

EPS

4.22

Balance Sheet

Cash

$1.7bn

Debt

$2.6bn

Assets

$10.9bn

Liabilities

$4.8bn

Equity

$6.2bn

Enterprise Value

$39.3bn

Cash Flow Statement

Net Cash from Operations

$2.0bn

Net Cash from Investing

$-0.3bn

Net Cash from Financing

$-1.2bn

Net Cash Flow

$497.0m

Free Cash Flow

$1.6bn

Free Cash Flow per Share

$5.63

Metrics

Price to Equity

30.84

Price to Equity (Damodaran)

30.83

Price to Book

6.16

Net Margin

0.18

Return on Equity

0.21

Return on Sales

0.21

Get immediate access to 5-years of reference grade data for A for free.

Sign up

Company Profile

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer''s representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Company Info

Industry

Diagnostics & Research

Employees

18,100

Address

5301 Stevens Creek Boulevard
Santa Clara, CA 95051
United States

Phone

800 227 9770

Last Updated

2024-02-19

Available Data

Standardized Financial Statements

EOD Price History

Corporate Actions

Institutional Holdings

Insider Transactions

Sign up for free and get immediate access
logo

Radically accessible financial data

Contact Info

findl.com info@findl.com

Explore findl data

DocumentationSupport

Copyright © findl 2024. All rights reserved.

Terms & Use

Privacy Policy